| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Artificial intelligence in peripheral blood films: an evolving landscape
|
Fan, Bingwen Eugene
|
|
|
9 |
3 |
p. e174
|
article
|
| 2 |
Artwork from trauma: the social life of medical data
|
Corby, Tom
|
|
|
9 |
3 |
p. e175-e176
|
article
|
| 3 |
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
|
Al-Samkari, Hanny
|
|
|
9 |
3 |
p. e179-e189
|
article
|
| 4 |
Chronic lymphocytic leukaemia therapy: is less more?
|
Walter, Harriet S
|
|
|
9 |
3 |
p. e169-e171
|
article
|
| 5 |
Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study
|
Ranque, Brigitte
|
|
|
9 |
3 |
p. e208-e216
|
article
|
| 6 |
Filling the data gaps on sickle cell anaemia in sub-Saharan Africa
|
Williams, Thomas Neil
|
|
|
9 |
3 |
p. e172-e173
|
article
|
| 7 |
Is acute myeloid leukaemia maintenance therapy necessary?
|
Ravandi, Farhad
|
|
|
9 |
3 |
p. e177-e178
|
article
|
| 8 |
Malignancy-associated haemophagocytic lymphohistiocytosis
|
Setiadi, Audi
|
|
|
9 |
3 |
p. e217-e227
|
article
|
| 9 |
Meeting the health needs of people from Afghanistan
|
The Lancet Haematology,
|
|
|
9 |
3 |
p. e167
|
article
|
| 10 |
Risk factors associated with venous and arterial neonatal thrombosis in the intensive care unit: a multicentre case-control study
|
Bhat, Rukhmi
|
|
|
9 |
3 |
p. e200-e207
|
article
|
| 11 |
Thrombopoietin receptor agonist in chemotherapy-induced thrombocytopenia
|
Lozano, Maria L
|
|
|
9 |
3 |
p. e168-e169
|
article
|
| 12 |
Transplantation for Fanconi anaemia: lessons learned from Brazil
|
Bonfim, Carmem
|
|
|
9 |
3 |
p. e228-e236
|
article
|
| 13 |
Understanding risk factors for neonatal thrombosis
|
Male, Christoph
|
|
|
9 |
3 |
p. e171-e172
|
article
|
| 14 |
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial
|
Kersting, Sabina
|
|
|
9 |
3 |
p. e190-e199
|
article
|
Journal description